2_tushield2_cv2
LCRC logo
LSUHSCSEAL3006v2
 

COBRE Cancer Genetics Program

 
Upcoming Meetings

 

    Date

                  Speaker

                              Title

May 24, 2012

           Ed Grabczyk, Ph.D.
            LSU Health Sciences Center
            Department of Genetics

                     Repeat Expansion: The Other Edge of the
                   Mismatch Repair Blade


 

Excerpt from an article by Melanie Cross.  For the entire article please see

NIH Awards Tulane University $11.1 Million COBRE Grant Renewal for Cancer Genetics Research Program

In the fall of 2009, the National Institutes of Health (NIH) awarded Prescott Deininger, Ph.D., director of the Tulane Cancer Center and co-director of the Louisiana Cancer Research Consortium (LCRC), $11.1 million to continue a successful mentorship program that supports and nurtures the next generation of promising cancer genetics researchers in New Orleans.

The award consists of a five-year, $10.5 million Center of Biomedical Research Excellence (COBRE) grant to continue a career development program affiliated with the Tulane Cancer Center and the LCRC. The center funds research projects for five junior faculty members and matches these investigators with a team of senior scientists in cancer genetics who act as mentors, guiding research progress as well as career development. 

Additionally, Dr. Deininger was awarded a two-year,  $599,393 supplemental grant from the 2009 American Recovery and Reinvestment Act (ARRA) to add a sixth junior faculty member to the program and four new mentors. The Center’s goal is to grow the pool of research scientists in cancer genetics in New Orleans by helping junior faculty get to the point where they can obtain their own major funding from NIH and other national programs.

“In an increasingly competitive environment, grants like this help New Orleans retain and attract some of the brightest new minds in cancer research,” said Dr. Deininger.  “It is getting increasingly more complex and competitive in cancer research. Scientists not only have to rely on and master more sophisticated equipment just to do their research, but they also must be equally adept at navigating the complex world of grant writing. We have to teach the next generation of cancer researchers the tricks of the trade and what it takes to get grant funding to continue their research.”